Recessively‐Inherited Adult‐Onset Alexander Disease Caused by a Homozygous Mutation in the GFAP Gene

• Published in: Movement disorders Vol. 35; no. 9; pp. 1662 - 1667
• Main Authors: Fu, Mu‐Hui, Chang, Yung‐Yee, Lin, Ni‐Hsuan, Yang, Ai‐Wen, Chang, Chiung‐Chih, Liu, Jia‐Shou, Peng, Cheng‐Huei, Wu, Kay, L.H., Perng, Ming‐Der, Lan, Min‐Yu
• Format: Journal Article
• Language: English
• Published: Hoboken, USA John Wiley & Sons, Inc 01.09.2020; Wiley Subscription Services, Inc
• Subjects: Adolescent; Adult; Alexander disease; Alexander Disease - diagnostic imaging; Alexander Disease - genetics; Alexander's disease; astrocyte; GFAP; Glial fibrillary acidic protein; Glial Fibrillary Acidic Protein - genetics; Homozygote; Humans; Leukodystrophy; Magnetic resonance imaging; Male; Movement disorders; Mutation; Mutation - genetics; Phenotype; Phenotypes; recessive mutation; Alexander disease; leukodystrophy; astrocyte; GFAP; recessive mutation
• ISSN: 0885-3185; 1531-8257; 1531-8257
• DOI: 10.1002/mds.28099

Background Alexander disease (AxD) is an autosomal‐dominant leukodystrophy caused by heterozygous mutations in the glial fibrillary acidic protein (GFAP) gene. Objectives The objective of this report is to characterize the clinical phenotype and identify the genetic mutation associated with adult‐onset AxD. Methods A man presented with progressive unsteadiness since age 16. Magnetic resonance imaging findings revealed characteristic features of AxD. The GFAP gene was screened, and a candidate variant was functionally tested to evaluate causality. Results A homozygous c.197G > A (p.Arg66Gln) mutation was found in the proband, and his asymptomatic parents were heterozygous for the same mutation. This mutation affected GFAP solubility and promoted filament aggregation. The presence of the wild‐type protein rescued mutational effects, consistent with the recessive nature of this mutation. Conclusions This study is the first report of AxD caused by a homozygous mutation in GFAP. The clinical implication is while examining patients with characteristic features on suspicion of AxD, GFAP screening is recommended even without a supportive family history. © 2020 International Parkinson and Movement Disorder Society